2021
DOI: 10.1242/jeb.242635
|View full text |Cite
|
Sign up to set email alerts
|

Early suppression of the endocannabinoid degrading enzymes FAAH and MAGL alters locomotor development in zebrafish

Abstract: The fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) enzymes are the predominant catabolic regulators of the major endocannabinoids (eCBs), anadamide (AEA) and 2-arachidonoylglycerol (2-AG), respectively. The expression and roles of eCBs during early embryogenesis remain to be fully investigated. Here, we inhibited FAAH and MAGL in zebrafish embryos during the first 24 hours of life and examined motor neuron and locomotor development at 2 and 5 days post fertilization (dpf). Application of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
18
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1
1

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(20 citation statements)
references
References 62 publications
2
18
0
Order By: Relevance
“…It was shown previously that zebrafish embryos exposed to the FAAH and MAGL inhibitors URB 597, JZL 184, and JZL 195 experience deficits in locomotion, and so here we examined the locomotor alterations caused by inhibiting these eCS catabolic enzymes (Khara et al, 2022 ; Sufian et al, 2021 ). Because FAAH and MAGL inhibition are linked to increased eCB levels, our investigation began by targeting the canonical cannabinoid receptors: CB1R and CB2R (Griebel et al, 2015 ; Zou & Kumar, 2018 ).…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…It was shown previously that zebrafish embryos exposed to the FAAH and MAGL inhibitors URB 597, JZL 184, and JZL 195 experience deficits in locomotion, and so here we examined the locomotor alterations caused by inhibiting these eCS catabolic enzymes (Khara et al, 2022 ; Sufian et al, 2021 ). Because FAAH and MAGL inhibition are linked to increased eCB levels, our investigation began by targeting the canonical cannabinoid receptors: CB1R and CB2R (Griebel et al, 2015 ; Zou & Kumar, 2018 ).…”
Section: Resultsmentioning
confidence: 99%
“…Along with these compounds, animals were co‐treated with the CB1R antagonist AM 251 (Selleck Chemicals), the CB2R antagonist AM630 (Adooq Bioscience), the TRPV1/TRPA1/TRPM8 inhibitor AMG 9090 (Alomone Labs), or the SMO agonist Purmorphamine (Sigma‐Aldrich). The concentrations used for these four drugs were 10 nM for AM 251, 1 μM for AM 630, 0.01 μM for AMG 9090, and 5 μM for purmorphamine and were determined based on previous studies (Khara et al, 2022 ; Sufian et al, 2021 ) and dose–response relationships performed for survival, hatching, morphology, and locomotion in embryos and larva. All compounds listed here were dissolved in dimethyl sulfoxide (DMSO), which was used as the vehicle control.…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations